Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Wednesday that its board of directors has approved a dividend for the fourth quarter of 2023.
The dividend of USD1.13 per share on outstanding common stock is payable to shareholders of record at 15 November 2023 on 8 December 2023.
Cardinal Health announces quarterly dividend of USD0.5006 per share
Egetis secures exclusive licence agreement with Fujimoto for Emcitate development in Japan
Perrigo announces quarterly dividend
Eli Lilly announces Q4 2023 dividend
Moderna and CEPI partner to accelerate mRNA vaccine development